A Rare Case Report of Postmenopausal Virilization: Ovarian Steroid Cell Tumor
Author(s) -
Mahbube Ebrahimpur,
Mohammad Reza Mohajeri–Tehrani,
Hiva Saffar,
Mahnaz Pejman Sani
Publication year - 2020
Publication title -
acta medica iranica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.218
H-Index - 27
eISSN - 1735-9694
pISSN - 0044-6025
DOI - 10.18502/acta.v57i12.3471
Subject(s) - virilization , medicine , hyperandrogenism , ovary , ovarian tumor , hysterectomy , testosterone (patch) , gynecology , pathology , androgen , ovarian cancer , hormone , cancer , polycystic ovary , insulin resistance , obesity
Ovarian steroid cell tumors are rare, life-threatening neoplasms that make about 0.1% of all primary ovarian tumors. They frequently present in premenopausal women with the manifestation of virilization. We report a 58-year-old postmenopausal woman that referred to our clinic with clinical manifestation of virilization. Laboratory findings showed markedly elevated serum testosterone level and ultrasound showed 2 follicles with 7 mm diameters in the left ovary. She treated by bilateral salpingo-oophorectomy and synchronous hysterectomy. Histological pathology confirmed a benign steroid cell tumor. The presentation of new-onset and rapid progressive hyperandrogenism is rare in postmenopausal women. In diagnosis, we must consider adrenal and ovarian malignancies. Stromal luteoma is a rare benign ovarian tumor, Which is treated with surgical treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom